NEW DELHI, April 21 (Reuters) - The Serum Institute of India
will be able to raise its monthly output of the AstraZeneca
COVID-19 vaccine to 100 million doses by July from 60-70 million
now, later than a previous timeline of end-May, its chief
executive Adar Poonawalla told CNBC-TV18.
(Reporting by Chandini Monappa and Krishna N. Das; Editing by
Andrew Heavens)
Angle shares jump on supplier agreement with with AstraZeneca
(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.
Read more